The company sources raw materials for its testing processes from a limited number of suppliers, including some single-source providers. It also depends on limited or single suppliers for certain services and equipment, such as the automation of deparaffination steps in the Confirm mdx test. Transitioning to alternative suppliers or initiating in-house production may result in delays. Previously, the company encountered issues with a supplier delivering non-conforming components, necessitating audits and quality improvements. Third-party suppliers may experience disruptions due to regulatory actions, natural disasters, epidemics, labor disputes, or financial difficulties, which could lead to extended service interruptions and affect clinical studies or commercialization efforts. Alternative suppliers may lack necessary regulatory approvals or quality systems, and changes to services or supplied items might require new regulatory approvals. Although no significant supply chain disruptions have occurred to date, future disruptions could materially affect revenues. Additionally, the company relies on IT systems for operations and data security, which are susceptible to various threats, including cyber-attacks.
Mdxhealth Sa's Comment on Supply Chain
The company sources raw materials for its testing processes from a limited number of suppliers, including some single-source providers. It also depends on limited or single suppliers for certain services and equipment, such as the automation of deparaffination steps in the Confirm mdx test. Transitioning to alternative suppliers or initiating in-house production may result in delays. Previously, the company encountered issues with a supplier delivering non-conforming components, necessitating audits and quality improvements. Third-party suppliers may experience disruptions due to regulatory actions, natural disasters, epidemics, labor disputes, or financial difficulties, which could lead to extended service interruptions and affect clinical studies or commercialization efforts. Alternative suppliers may lack necessary regulatory approvals or quality systems, and changes to services or supplied items might require new regulatory approvals. Although no significant supply chain disruptions have occurred to date, future disruptions could materially affect revenues. Additionally, the company relies on IT systems for operations and data security, which are susceptible to various threats, including cyber-attacks.
Sources:
Mdxhealth Sa's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Mdxhealth Sa’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
